Nutrition Therapy

Canadian Journal of Diabetes

Volumn 37, Issue SUPPL.1, 2013, Pages

  Dworatzek, Paula D ^a   Arcudi, Kathryn ^a   Gougeon, Réjeanne ^a   Husein, Nadira ^a   Sievenpiper, John L ^a   Williams, Sandra L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALCOHOL; CARBOHYDRATE; FAT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MINERAL; MONOSATURATED FATTY ACID; OMEGA 3 FATTY ACID; PROTEIN; SATURATED FATTY ACID; SUCROSE; SUGAR; UNCLASSIFIED DRUG; VITAMIN;

ARTICLE; BODY WEIGHT; CALORIC RESTRICTION; CANADA; CARBOHYDRATE INTAKE; CARDIOVASCULAR RISK; DIABETES CONTROL; DIABETES MELLITUS; DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY APPROACHES TO STOP HYPERTENSION DIETARY PATTERN; DIETARY FIBER; DIETITIAN; ENERGY; FITNESS; FOOD INTAKE; GLYCEMIC CONTROL; GLYCEMIC INDEX; HEALTH CARE PLANNING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE MODIFICATION; MACRONUTRIENT; MEDITERRANEAN DIET; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONNUTRITIVE SWEETENER; NUTRITION EDUCATION; NUTRITIONAL COUNSELING; NUTRITIONAL HEALTH; OBESITY; PATIENT CARE; PHYSICAL ACTIVITY; QUALITY OF LIFE; SODIUM RESTRICTION; VEGETARIAN DIET; WEIGHT CONTROL; WEIGHT LOSS DIET; PRACTICE GUIDELINE;

CANADA; DIABETES MELLITUS; HUMANS; NUTRITION THERAPY;

EID: 84876021542     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcjd.2013.01.019     Document Type: Article

References (173)

1. Pastors J.G., Warshaw H., Daly A., et al. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care 2002, 25:608-613.
2. Pi-Sunyer F.X., Maggio C.A., McCarron D.A., et al. Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes. Diabetes Care 1999, 22:191-197.
3. Franz M.J., Monk A., Barry B., et al. Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial. J Am Diet Assoc 1995, 95:1009-1017.
4. Kulkarni K., Castle G., Gregory R., et al. Nutrition practice guidelines for type 1 diabetes mellitus positively affect dietitian practices and patient outcomes. The Diabetes Care and Education Dietetic Practice Group. J Am Diet Assoc 1998, 98:62-70.
5. Gaetke L., Stuart M., Truszczynska H. A single nutrition counseling session with a registered dietitian improves short-term clinical outcomes for rural kentucky patients with chronic diseases. J Am Diet Assoc 2006, 106:109-112.
6. Imai S., Kozai H., Matsuda M., et al. Intervention with delivery of diabetic meals improves glycemic control in patients with type 2 diabetes mellitus. J Clin Biochem Nutr 2008, 42:59-63.
7. Huang M.-C., Hsu C.-C., Wang H.-S., et al. Prospective randomized controlled trial to evaluate effectiveness of registered dietitian-led diabetes management on glycemic and diet control in a primary care setting in Taiwan. Diabetes Care 2010, 33:233-239.
8. Robbins J.M., Thatcher G.E., Webb D.A., et al. Nutritionist visits, diabetes classes, and hospitalization rates and charges: the Urban Diabetes Study. Diabetes Care 2008, 31:655-660.
9. Willaing I., Ladelund S., Jørgensen T., et al. Nutritional counselling in primary health care: a randomized comparison of an intervention by general practitioner or dietician. Eur J Cardiovasc Prev Rehabil 2004, 11:513-520.
10. Wilson C., Brown T., Acton K., et al. Effects of clinical nutrition education and educator discipline on glycemic control outcomes in the Indian health service. Diabetes Care 2003, 26:2500-2504.
11. Brekke H.K., Jansson P.A., Lenner R.A. Long-term (1- and 2-year) effects of lifestyle intervention in type 2 diabetes relatives. Diabetes Res Clin Pract 2005, 70:225-234.
12. Lemon C.C., Lacey K., Lohse B., et al. Outcomes monitoring of health, behavior, and quality of life after nutrition intervention in adults with type 2 diabetes. J Am Diet Assoc 2004, 104:1805-1815.
13. Rickheim P.L., Weaver T.W., Flader J.L., et al. Assessment of group versus individual diabetes education: a randomized study. Diabetes Care 2002, 25:269-274.
14. Trento M., Basile M., Borgo E., et al. A randomised controlled clinical trial of nurse-, dietitian- and pedagogist-led Group Care for the management of type 2 diabetes. J Endocrinol Invest 2008, 31:1038-1042.
15. Pérez-Escamilla R., Hromi-Fiedler A., Vega-López S., et al. Impact of peer nutrition education on dietary behaviors and health outcomes among Latinos: a systematic literature review. J Nutr Educ Behav 2008, 40:208-225.
16. Ralston J.D., Hirsch I.B., Hoath J., et al. Web-based collaborative care for type 2 diabetes: a pilot randomized trial. Diabetes Care 2009, 32:234-239.
17. Marcy T.R., Britton M.L., Harrison D. Identification of barriers to appropriate dietary behavior in low-income patients with type 2 diabetes mellitus. Diabetes Ther 2011, 1:9-19.
18. Health Canada Eating Well with Canada's Food Guide. Publication H39e166/1990E 2007, Health Products and Food Branch, Office of Nutrition and Promotion, Ottawa, ON.
19. Norris S.L., Engelgau M.M., Narayan K.M. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001, 24:561-587.
20. Ash S., Reeves M.M., Yeo S., et al. Effect of intensive dietetic interventions on weight and glycaemic control in overweight men with Type II diabetes: a randomised trial. Int J Obes Relat Metab Disord 2003, 27:797-802.
21. Clement S. Diabetes self-management education. Diabetes Care 1995, 18:1204-1214.
22. Vallis T.M., Higgins-Bowser I., Edwards L., et al. The role of diabetes education in maintaining lifestyle changes. Can J Diabetes 2005, 29:193-202.
23. Christensen N.K., Terry R.D., Wyatt S., et al. Quantitative assessment of dietary adherence in patients with insulin-dependent diabetes mellitus. Diabetes Care 1983, 6:245-250.
24. Toeller M., Klischan A., Heitkamp G., et al. Nutritional intake of 2868 IDDM patients from 30 centres in Europe. EURODIAB IDDM Complications Study Group. Diabetologia 1996, 39:929-939.
25. Glazier R.H., Bajcar J., Kennie N.R., et al. A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care 2006, 29:1675-1688.
26. Wing R.R. Weight loss in the management of type 2 diabetes. Evidence-Based Diabetes Care 2000, 252-276. B.C. Decker, Inc, Ontario, Canada. H.C. Gerstein, B. Haynes (Eds.).
27. Tuomilehto J., Lindström J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350. Finnish Diabetes Prevention Study Group.
28. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403. Diabetes Prevention Program Research Group.
29. Wing R.R. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010, 170:1566-1575. Look AHEAD Research Group.
30. Knowler W.C., Fowler S.E., Hamman R.F., et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009, 374:1677-1686. Diabetes Prevention Program Research Group, Published erratum in: Lancet. 2009;374:2054.
31. Lindström J, Ilanne-Parikka P., Peltonen M., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368:1673-1679. Finnish Diabetes Prevention Study Group.
32. Institute of Medicine, Food and Nutrition Board Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids 2002, National Academies Press, Washington, DC.
33. Kirk J.K., Graves D.R., Carven T.E., et al. Restricted carbohydrate diet in patients with type 2 diabetes: A meta-analysis. J Am Diet Assoc 2008, 108:91-100.
34. Barnard N.D., Cohen J., Jenkins D.J., et al. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care 2006, 29:1777-1783.
35. Jenkins D.J., Wolever T.M., Taylor R.H., et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981, 34:362-366.
36. Atkinson F.S., Foster-Powell K., Brand-Miller J.C. International tables of glycemic index and glycemic load values. Diabetes Care 2008, 31:2281-2283.
37. Brand-Miller J., Hayne S., Petocz P., et al. Low glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2003, 26:2261-2267.
38. Opperman A.M., Venter C.S., Oosthuizen W., et al. Meta-analysis of the health effects of using the glycaemic index in meal-planning. Br J Nutr 2004, 92:367-381.
39. Thomas D.E., Elliott E.J. The use of low-glycaemic index diets in diabetes control. Br J Nutr 2010, 104:797-802.
40. Wolever T.M., Gibbs A.L., Mehling C., et al. The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr 2008, 87:114-125.
41. Jenkins D.J., Kendall C.W., McKeown-Eyssen G., et al. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 2008, 300:2742-2753.
42. Wolever T.M., Mehling C., Chiasson J.L., et al. Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of carbohydrates in diabetes): a randomised controlled trial. Diabetologia 2008, 51:1607-1615.
43. Amano Y., Sugiyama M., Lee J.S., et al. Glycemic index-based nutritional education improves blood glucose control in Japanese adults: a randomized controlled trial. Diabetes Care 2007, 30:1874-1876.
44. Ma Y., Olendzki B.C., Merriam P.A., et al. A randomized clinical trial comparing low-glycemic index versus ADA dietary education among individuals with type 2 diabetes. Nutrition 2008, 24:45-56.
45. Anderson J.W., Randles K.M., Kendall C.W., et al. Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr 2004, 23:5-17.
46. Jacobs D.R., Meyer K.A., Kushi L.H., et al. Whole-grain intake may reduce the risk of ischemic heart disease death in post-menopausal women: the Iowa Women's Health Study. Am J Clin Nutr 1998, 68:248-257.
47. Acceptable macronutrient distribution ranges. Dietary Reference Intakes 2006, 70. National Academies Press, Washington, DC. J. Otten, J. Hellwig, L. Meyer (Eds.).
48. Chandalia M., Garg A., Lutjohann D., et al. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000, 342:1392-1398.
49. Cooper P.L., Wahlqvist M.L., Simpson R.W. Sucrose versus saccharin as an added sweetener in non-insulin-dependent diabetes: short- and medium-term metabolic effects. Diabet Med 1988, 5:676-680.
50. Chantelau E.A., Gösseringer G., Sonnenberg G.E., et al. Moderate intake of sucrose does not impair metabolic control in pump-treated diabetic out-patients. Diabetologia 1985, 28:204-207.
51. Colagiuri S., Miller J.J., Edwards R.A. Metabolic effects of adding sucrose and aspartame to the diet of subjects with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1989, 50:474-478.
52. Coulston A.M., Hollenbeck C.B., Donner C.C., et al. Metabolic effects of added dietary sucrose in individuals with noninsulin-dependent diabetes mellitus (NIDDM). Metabolism 1985, 34:962-966.
53. Jellish W.S., Emanuele M.A., Abraira C. Graded sucrose/carbohydrate diets in overtly hypertriglyceridemic diabetic patients. Am J Med 1984, 77:1015-1022.
54. Sievenpiper J.L., de Souza R.J., Mirrahimi A., et al. Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Intern Med 2012, 156:291-304.
55. Sievenpiper J.L., Chiavaroli L., de Souza R.J., et al. "Catalytic" doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: a small meta-analysis of randomised controlled feeding trials. Br J Nutr 2012, 108:418-423.
56. Ha V., Sievenpiper J.L., de Souza R.J., et al. Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension 2012, 59:787-795.
57. Wang D.D., Sievenpiper J.L., de Souza R.J., et al. Effect of fructose on uric acid: a meta-analysis of controlled feeding trials. J Nutr 2012, 142:916-923.
58. Cozma A.I., Sievenpiper J.L., de Souza R.J., et al. Effect of fructose on glycemic control in diabetes: a meta-analysis of controlled feeding trials. Diabetes Care 2012, 35:1611-1620.
59. Livesey G., Taylor R. Fructose consumption and consequences for glycation, plasmid triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr 2008, 88:1419-1437.
60. Sievenpiper J.L., Carleton A.J., Chatha S., et al. Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans. Diabetes Care 2009, 32:1930-1937.
61. Madero M., Arriaga J.C., Jalal D., et al. The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: A randomized controlled trial. Metabolism 2011, 60:1551-1559.
62. Jenkins D.J., Srichaikul K., Kendall C.W., et al. The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes. Diabetologia 2011, 54:271-279.
63. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.
64. McEwan B., Morel-Kopp M.-C., Tofler G., Ward C. Effect of omega-3 fish oil on cardiovascular risk in diabetes. Diabetes Educ 2010, 36:565-584.
65. Hu F.B., Cho E., Rexrode K.M., et al. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 2003, 107:1852-1857.
66. Lee C.C., Sharp S., Wexler D., Adler A. Dietary intake of eicosapentaenoic and docosahexaenoic acid and diabetic nephropathy: cohort analysis of the diabetes control and complications trial. Diabetes Care 2010, 33:1454-1456.
67. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
68. GISSI-HF Investigators Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1223-1230.
69. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999, 354:447-455.
70. Kromhout D., Giltay E.J., Geleijnse J.M. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010, 363:2015-2026. Alpha Omega Trial Group.
71. ORIGIN Trial Investigators, Bosch J., Gerstein H.C., Dagenais G.R., et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012, 367:309-318.
72. Rizos E.C., Ntzani E.E., Bika E., et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012, 308:1024e33.
73. Hamdy O., Horton E.S. Protein content in diabetes nutrition plan. Curr Diab Rep 2011, 11:111-119.
74. Food and Nutrition Board, Institute of Medicine Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids 2005, National Academies Press, Washington, DC.
75. Hansen H.P., Tauber-Lassen E., Jensen B.R., Parving H.H. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 2002, 62:220-228.
76. Pan Y., Guo L.L., Jin H.M. Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008, 88:660-666.
77. Azadbakht L., Esmaillzadeh A. Soy-protein consumption and kidney-related biomarkers among type 2 diabetics: a crossover, randomized clinical trial. J Ren Nutr 2009, 19:479-486.
78. Azadbakht L., Atabak S., Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 2008, 31:648-654.
79. Teixeira S.R., Tappenden K.A., Carson L., et al. Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 2004, 134:1874-1880.
80. de Mello V.D., Zelmanovitz T., Perassolo M.S., et al. Withdrawal of red meat from the usual diet reduces albuminuria and improves serum fatty acid profile in type 2 diabetes patients with macroalbuminuria. Am J Clin Nutr 2006, 83:1032-1038.
81. Brodsky I.G., Robbins D.C., Hiser E., et al. Effects of low-protein diets on protein metabolism in insulin-dependent diabetes mellitus patients with early nephropathy. J Clin Endocrinol Metab 1992, 75:351-357.
82. Rodrigues-Villar C., Pérez-Heras A., Mercadé I., et al. Effects of olive oil on lipid profiles and blood glucose in type 2 diabetic patients. Diabet Med 2004, 21:142-149.
83. Brehm B.J., Lattin B.L., Summer S.S., et al. One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes. Diabetes Care 2009, 32:215-220.
84. Brunerova L., Smejkalova V., Potockova J., et al. A comparison of the influence of a high-fat diet enriched in monounsaturated fatty acids and conventional diet on weight loss and metabolic parameters in obese non-diabetic and Type 2 diabetic patients. Diabet Med 2007, 24:533-540.
85. De Natale C., Annuzzi G., Bozzetto L., et al. Effects of a plant-based high carbohydrate/high fibre diet versus high monounsaturated fat/low carbohydrate diet on postprandial lipids in type 2 diabetic patients. Diabetes Care 2009, 32:2168-2173.
86. Kodama S., Saito K., Tanaka S., et al. Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: a meta-analysis. Diabetes Care 2009, 32:959-965.
87. Papakonstantinou E., Zampelas A. The effect of dietary protein intake on coronary heart disease risk. J Hum Nutr Diet 2010, 23:183-189.
88. Paddon-Jones D., Westman E., Mattes R.D., et al. Protein, weight management, and satiety. Am J Clin Nutr 2008, 87:1558S-1561S.
89. Lejeune M.P., Westerterp K.R., Adam T.C., et al. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am J Clin Nutr 2006, 83:89-94.
90. Mozaffarian D., Micha R., Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010, 7:e1000252.
91. Jakobsen M.U., O'Reilly E.J., Heitmann B.L., et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009, 89:1425-1432.
92. Howard B.V., Van Horn L., Hsia J., et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006, 295:655-666.
93. Larsen R.N., Mann N.J., Maclean E., et al. The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial. Diabetologia 2011, 54:731-740.
94. McLaughlin T., Carter S., Lamendola C., et al. Clinical efficacy of two hypocaloric diets that vary in overweight patients with type 2 diabetes: comparison of moderate fat versus carbohydrate reductions. Diabetes Care 2007, 30:1877-1879.
95. Brinkworth G.D., Noakes M., Parker B., et al. Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with Type 2 diabetes: one-year follow-up of a randomized trial. Diabetologia 2004, 47:1677-1686.
96. Pearce K.L., Clifton P.M., Noakes M. Egg consumption as part of an energy-restricted high-protein diet improves blood lipid and blood glucose profiles in individuals with type 2 diabetes. Br J Nutr 2011, 105:585-592.
97. Haimoto H., Iwata M., Wakai K., et al. Long-term effects of a diet loosely restricting carbohydrates on HbA1c levels, BMI and tapering of sulfonylureas in type 2 diabetes: a 2-year follow-up study. Diabetes Res Clin Pract 2008, 79:350-356.
98. Davis N.J., Tomuta N., Schechter C., et al. Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes. Diabetes Care 2009, 32:1147-1152.
99. Gong Q., Gregg E.W., Wang J., et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 2011, 54:300-307.
100. Mann J.I., De Leeuw I., Hermansen K., et al. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 2004, 14:373-394.
101. Coppell K.J., Kataoka M., Williams S.M., et al. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment-Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial. BMJ 2010, 341:c3337.
102. Toobert D.J., Glasgow R.E., Strycker L.A., et al. Biologic and quality-of-life outcomes from the Mediterranean Lifestyle Program: a randomized clinical trial. Diabetes Care 2003, 26:2288-2293.
103. Barnard N.D., Cohen J., Jenkins D.J.A., et al. A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial. Am J Clin Nutr 2009, 89:1588S-1596S.
104. Kahleova H., Matoulek M., Malinska H., et al. Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with Type 2 diabetes. Diabet Med 2011, 28:549-559.
105. Willett W.C., Sacks F., Trichopoulou A., et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995, 61:1402S-1406S.
106. Trichopoulou A., Costacou T., Bamia C., et al. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003, 348:2599-2608.
107. Esposito K., Maiorino M.I., Ceriello A., et al. Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review. Diabetes Res Clin Pract 2010, 89:97-102.
108. Esposito K., Maiorino M.I., Ciotola M., et al. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Ann Intern Med 2009, 151:306-314.
109. Shai I., Schwarzfuchs D., Henkin Y., et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008, 359:229-241. Published erratum in: N Engl J Med. 2009;361:2681.
110. Elhayany A., Lustman A., Abel R., et al. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. Diabetes Obes Metab 2010, 12:204-209.
111. Estruch R., Ros E., Salas-Salvadó J., et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013, [Epub ahead of print].
112. Food and Nutrition Board, Institute of Medicine Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate 2004, National Academies Press, Washington, DC.
113. Thomas M.C., Moran J., Forsblom C., et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011, 34:861-866.
114. Ekinci E.I., Clarke S., Thomas M.C., et al. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 2011, 34:703-709.
115. Appel L.J., Moore T.J., Obarzanek E., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997, 336:1117-1124.
116. Sacks F.M., Svetkey L.P., Vollmer W.M., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001, 344:3-10. DASH-Sodium Collaborative Research Group.
117. Azadbakht L., Surkan P.J., Esmaillzadeh A., et al. The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. J Nutr 2011, 141:1083-1088.
118. Azadbakht L., Fard N.R., Karimi M., et al. Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes Care 2011, 34:55-57.
119. Nordmann A.J., Nordmann A., Briel M., et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 2006, 166:285-293.
120. Stern L., Iqbal N., Seshadri P., et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 2004, 140:778-785.
121. Dansinger M.L., Gleason J.A., Griffith J.L., et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005, 293:43-53.
122. Sievenpiper J.L., Kendall C.W.C., Esfahani A., et al. Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia 2009, 52:1479-1495.
123. Jang Y., Lee J.H., Kim O.Y., et al. Consumption of whole grain and legume powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in patients with coronary artery disease: randomized controlled clinical trial. Arterioscler Thromb Vasc Biol 2001, 12:2065-2071.
124. Bazzano L.A., Thompson A.M., Tees M.T., et al. Non-soy legume consumption lowers cholesterol levels: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2011, 2:94-103.
125. Imai S., Matsuda M., Hasegawa G., et al. A simple meal plan of "eating vegetables before carbohydrate" was more effective for achieving glycemic control than an exchange-based meal plan in Japanese patients with type 2 diabetes. Asia Pac J Clin Nutr 2011, 20:161-168.
126. Jenkins D.J., Kendall C.W., Banach M.S., et al. Nuts as a replacement for carbohydrates in the diabetic diet. Diabetes Care 2011, 34:1706-1711.
127. Cohen A.E., Johnston C.S. Almond ingestion at mealtime reduces postprandial glycemia and chronic ingestion reduces hemoglobin A1C in individuals with well-controlled type 2 diabetes mellitus. Metabolism 2011, 6:1312-1317.
128. Li S.-C., Liu Y.-H., Liu J.-F., et al. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism 2011, 60:474-479.
129. Lovejoy J.C., Most M.M., Lefevre M., et al. Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr 2002, 76:1000-1006.
130. Sabaté J., Oda K., Ros E. Nut consumption and blood lipid levels. Arch Intern Med 2010, 170:821-827.
131. Wolever T.M., Hamad S., Chiasson J.L., et al. Day-to-day consistency in amount and source of carbohydrate associated with improved blood glucose control in type 1 diabetes. J Am Coll Nutr 1999, 18:242-247.
132. Savoca M.R., Miller C.K., Ludwig D.A. Food habits are related to glycemic control among people with type 2 diabetes mellitus. J Am Diet Assoc 2004, 104:560-566.
133. Kalergis M., Schiffrin A., Gougeon R., et al. Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undergoing intensive insulin management using lispro insulin before meals: a randomized, placebo-controlled, crossover trial. Diabetes Care 2003, 26:9-15.
134. Arnold L., Mann J.I., Ball M.J. Metabolic effects of alterations in meal frequency in type 2 diabetes. Diabetes Care 1997, 20:1651-1654.
135. Delahanty L.M., Nathan D.M., Lachin J.M., et al. Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial. Am J Clin Nutr 2009, 89:518-524.
136. Tunbridge F.K., Home P.D., Murphy M., et al. Does flexibility at mealtimes disturb blood glucose control on a multiple insulin injection regimen?. Diabet Med 1991, 8:833-838.
137. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002, 325:746. DAFNE Study Group.
138. Scavone G., Manto A., Pitocco D., et al. Effect of carbohydrate counting and medical nutritional therapy on glycaemic control in Type 1 diabetic subjects: a pilot study. Diabet Med 2010, 27:477-479.
139. Bergenstal R.M., Johnson M., Powers M.A., et al. Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care 2008, 31:1305-1310.
140. Gillespie S.J., Kulkarni K.D., Daly A.E. Using carbohydrate counting in diabetes clinical practice. J Am Diet Assoc 1998, 98:897-905.
141. Kelley D.E. Sugars and starch in the nutritional management of diabetes mellitus. Am J Clin Nutr 2003, 78:858S-864S.
142. Rossi M.C., Nicolucci A., Di Bartolo P., et al. Diabetes Interactive Diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized study. Diabetes Care 2010, 33:109-115.
143. Gougeon R., Spidel M., Lee K., et al. Canadian Diabetes Association National Nutrition Committee Technical Review: non-nutritive intense sweeteners in diabetes management. Can J Diabetes 2004, 28:385-399.
144. JECFA 2008: Joint FAO/WHO Expert Committee on Food Additives. Sixty-ninth meeting. Rome, Italy, June 17-26, 2008.
145. Maki K.C., Curry L.L., Reeves M.S., et al. Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem Toxicol 2008, 46:S47-S53.
146. Barriocanal L.A., Palacios M., Benitez G., et al. Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics. Regul Toxicol Pharmacol 2008, 51:37-41.
147. Wang Y.M., van Eys J. Nutritional significance of fructose and sugar alcohols. Annu Rev Nutr 1981, 1:437-475.
148. Wolever T.M.S., Piekarz A., Hollands M., et al. Sugar alcohols and diabetes: a review. Can J Diabetes 2002, 26:356-362.
149. Stirban A., Negrean M., Götting C., et al. Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines. Ann N Y Acad Sci 2008, 1126:276-279.
150. Negrean M., Stirban A., Stratmann B., et al. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 2007, 85:1236-1243.
151. Uribarri J., Cai W., Ramdas M., et al. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care 2011, 34:1610-1616.
152. Heymsfield S.B., van Mierlo C.A., van der Knaap H.C., et al. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord 2003, 27:537-549.
153. Li Z., Hong K., Saltsman P., et al. Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 2005, 59:411-418.
154. Cheskin L.J., Mitchell A.M., Jhaveri A.D., et al. Efficacy of meal replacements versus a standard food-based diet for weight loss in type 2 diabetes: a controlled clinical trial. Diabetes Educ 2008, 34:118-127.
155. Yip I., Go V.L., DeShields S., et al. Liquid meal replacements and glycemic control in obese type 2 diabetes patients. Obes Res 2001, 9:341S-374S.
156. Wadden T.A., West D.S., Neiberg R.H., et al. One-year weight losses in the Look AHEAD study: factors associated with success. Obesity 2009, 17:713-722.
157. McCargar L., Innis S., Bowron E., et al. Effect of enteral nutritional products differing in carbohydrate and fat on indices of carbohydrate and lipid metabolism in patients with NIDDM. Mol Cell Biochem 1998, 188:81-89.
158. Lansink M., van Laere K.M., Vendrig L., et al. Lower postprandial glucose responses at baseline and after 4 weeks use of a diabetes-specific formula in diabetes type 2 patients. Diabetes Res Clin Pract 2011, 93:421-429.
159. Stockwell T., Zhao J., Thomas G. Should alcohol policies aim to reduce total alcohol consumption? New analyses of Canadian drinking patterns. Addict Res Theory 2009, 17:135-151.
160. Butt P., Beirness D., Cesa F., et al. Alcohol and health in Canada: a summary of evidence and guidelines for low-risk drinking 2011, Canadian Centre on Substance Abuse, Ottawa, ON.
161. Kerr D., Macdonald I.A., Heller S.R., et al. Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with type 1 (insulin-dependent) diabetes. Diabetologia 1990, 33:216-221.
162. Kerr D., Penfold S., Zouwail S., et al. The influence of liberal alcohol consumption on glucose metabolism in patients with type 1 diabetes: a pilot study. QJM 2009, 102:169-174.
163. Koppes L.L.J., Dekker J.M., Hendricks H.F.J., et al. Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients. Diabetologia 2006, 49:648-652.
164. Bantle A.E., Thomas W., Bantle J.P. Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus. Metabolism 2008, 57:241-245.
165. Marfella R., Cacciapuoti F., Siniscalchi M., et al. Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus. Diabet Med 2006, 23:974-981.
166. Nakamura T., Fujiwara N., Sugaya T., et al. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy. Metabolism 2009, 58:1185-1190.
167. Lee C.C., Stolk R.P., Adler A.I., et al. Association between alcohol consumption and diabetic retinopathy and visual acuity: the AdRem Study. Diabet Med 2010, 27:1130-1137.
168. Wakabayashi J. Association between alcohol drinking and metabolic syndrome in Japanese male workers with diabetes mellitus. J Atheroscler Thromb 2011, 18:684-691.
169. Ahmed A.T., Karter A.J., Warton M., et al. The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry. J Gen Intern Med 2008, 23:275-282.
170. Richardson T., Weiss M., Thomas P., et al. Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care 2005, 28:1801-1802.
171. Cheyne E.H., Sherwin R.S., Lunt M.J., et al. Influence of alcohol on cognitive performance during mild hypoglycaemia: implications for Type 1 diabetes. Diabet Med 2004, 21:230-237.
172. Pietraszek A., Gregersen S., Hermansen K. Alcohol and type 2 diabetes. A review. Nutr Metab Cardiovasc Dis 2010, 20:366-375.
173. Gallagher A., Connolly V., Kelly W.F. Alcohol consumption in patients with diabetes. Diabet Med 2001, 18:72-73.